Development and characterization of a canine oral mucosa equivalent in a serum-free environment

Journal of Biomedical Materials Research - Part A

Volumn 71, Issue 1, 2004, Pages 143-153

  Song, Junhui ^a   Izumi, Kenji ^a,b   Lanigan, Thomas ^a   Feinberg, Stephen E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Canine model; ex vivo produced oral mucosa equivalent (EVPOME); Green fluorescent protein (GFP); Keratinocyte; Serum free culture system

Indexed keywords

CELLS; GENES; MICROSCOPIC EXAMINATION; PROTEINS;

EPITHELIAL LAYERS; GREEN FLUORESCENT PROTEIN (GFP); KERATINOCYTES; ORAL MUCOSA;

BIOMEDICAL ENGINEERING;

GREEN FLUORESCENT PROTEIN; INVOLUCRIN; KI 67 ANTIGEN; LENTIVIRUS VECTOR; PROTEIN P63;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOPLASM; DERMIS; DISSOCIATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HEMOCONCENTRATION; HISTOLOGY; IMMUNOCHEMISTRY; KERATINOCYTE; MOUTH MUCOSA; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; SYSTEM ANALYSIS; TECHNIQUE;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DOGS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MATERIALS TESTING; MOUTH MUCOSA; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 4544273151     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30144     Document Type: Article

References (36)

1. Feinberg SE. Tissue-engineered mucosa graft for reconstruction of the intraoral lining after freeing of the tongue: a clinical and immunohistologic study. Oral Maxillofac Surg 2001;59:175-177. Discussion.
2. Izumi K, Feinberg SE, Iida A, Yoshizawa M. Intraoral grafting of an ex vivo produced oral mucosa equivalent: a preliminary report. Int J Oral Maxillofac Surg 2003;32:188-197.
3. Izumi K, Terashi H, Marcelo CL, Feinberg SE. Development and characterization of a tissue-engineered human oral mucosa equivalent produced in a serum-free culture system. J Dent Res 2000;79:798-805.
4. Izumi K, Feinberg SE, Terashi H, Marcelo CL. Evaluation of transplanted tissue-engineered oral mucosa equivalents in severe combined immunodeficient mice. Tissue Eng 2003;9:163-174.
5. Izumi K, Song J, Feinberg SE. Development of a tissue engineered human oral mucosa: from the bench to the bed side. Cells Tissues Organs 2004;176:134-152.
6. Chan LS. Mucous membrane pemphigoid. Dermatol Clin 2001;19:703-711.
7. Nicholls PK, Doorbar J, Moore RA, Peh W, Anderson DM, Stanley MA. Detection of viral DNA and E4 protein in basal keratinocytes of experimental canine oral papillomavirus lesions. Virology 2001;284:82-98.
8. Dillberger JE, Altman NH. Focal mucinosis in dogs: seven cases and review of cutaneous mucinoses of man and animals. Vet Pathol 1986;23(2):132-139.
9. Crameri FM, Varvayanis M, Cromie BR, Rekers WL, Suter MM. Serum-free conditions for the long term growth and differentiation of neoplastic canine keratinocytes. Exp Dermatol 1997;6:147-155.
10. Wilkinson JE, Smith C, Suter M, Lewis RM. Long-term cultivation of canine keratinocytes. J Invest Dermatol 1987;88:202-206.
11. Ophof R, van Rheden RE, Von den HJ, Schalkwijk J, Kuijpers-Jagtman AM. Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue. Biomaterials 2002;23:3741-3748.
12. Suter MM, Pantano DM, Flanders JA, Augustin-Voss HG, Dougherty EP, Varvayanis M. Comparison of growth and differentiation of normal and neoplastic canine keratinocyte cultures. Vet Pathol 1991;28:131-138.
13. Feinberg SE, Krishnan V, Gordillo G, Shuler CF. Intraoral grafting of a canine full-thickness oral mucosal equivalent produced in vitro. J Oral Maxillofac Surg 1989;47:712-718.
14. Ian Freshney R. Culture of animal cells. New York: John Wiley & Sons; 2000. p 321-323.
15. Izumi K, Takacs G, Terashi H, Feinberg SE. Ex vivo development of a composite human oral mucosal equivalent. J Oral Maxillofac Surg 1999;57:571-577.
16. van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, Hellebrekers L, Hyllner J, Jonker FH, Prieto P, Thalen M, Baumans V. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 2004;18:1-12.
17. Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997;89:776-779.
18. Marchese C, Felici A, Visco V, Lucania G, Igarashi M, Picardo M, Frati L, Torrisi MR. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol 2001;116:623-628.
19. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z. Calcium- and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 2001;177:161-171.
20. Lauer G, Siegmund C, Hubner U. Influence of donor age and culture conditions on tissue engineering of mucosa autografts. Int J Oral Maxillofac Surg 2003;32:305-312.
21. Dazard J-E, Piette J, Basset-Seguin N, Blanchard J-M, Gandarillas A. Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size. Oncogene 2000;19:3693-3705.
22. Altankov G, Hecht J, Dimoudis N. Serum-free cultured keratinocytes fail to organize fibronectin matrix and possess different distribution of beta-1 integrins. Exp Dermatol 2001;10:80-89.
23. Kaighn ME, Carnalier RF, Bertolero F, Saffiotti U. Spontaneous establishment and characterization of mouse keratinocyte cell lines in serum-free medium. In Vitro Cell Dev Biol 1988;24:845-854.
24. Marcelo CL, Rhodes LM, Dunham WR. Normalization of essential-fatty-acid- deficient keratinocytes requires palmitic acid. J Invest Dermatol 1994;103:564-568.
25. Strachan DS. Histology of the oral mucosa and tonsils. In: Avery JK, editor. Oral development and histology. New York: Thieme Medical Publishers; 1994. p 298-320.
26. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316.
27. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001;98(6): 3156-3161.
28. Andreadis ST, Hamoen KE, Yarmush ML, Morgan JR. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J 2001;15:898-906.
29. Watt FM. Stem cell fate and patterning in mammalian epidermis. Curr Opin Genet Dev 2001;11:410-417.
30. Janes SM, Lowell S, Hutter C. Epidermal stem cells. J Pathol 2002;197:479-491.
31. Lauer G, Schimming R. Tissue-engineered mucosa graft for reconstruction of the intraoral lining after freeing of the tongue: a clinical and immunohistologic study. J Oral Maxillofac Surg 2001;59:169-175.
32. Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000;2(5):308-316.
33. Baek SC, Lin Q, Robbins PB, Fan H, Khavari PA. Sustainable systemic delivery via a single injection of lentivirus into human skin tissue. Hum Gene Ther 2001;12:1551-1558.
34. Kuhn U, Terunuma A, Pfutzner W, Foster RA, Vogel JC. In vivo assessment of gene delivery to keratinocytes by lentiviral vectors. J Virol 2002;76:1496-1504.
35. Chen M, Li W, Fan J, Kasahara N, Woodley D. An efficient gene transduction system for studying gene function in primary human dermal fibroblasts and epidermal keratinocytes. Clin Exp Dermatol 2003;28:193-199.
36. Bickenbach JR, Dunnwald M. Epidermal stem cells: characteristics and use in tissue engineering and gene therapy. Adv Dermatol 2000;16:159-183.